U.S. Department of Health & Human Services
National Institutes of Health
NCATS
This repository is under review for potential modification in compliance with Administration directives.
Dismiss
Return Home
Inxight
Drugs
Search Substances
Home
Browse Drugs
US Approved Drugs
Marketed Drugs
Investigational Drugs
All Substances
Search
Structure Search
Sequence Search
Downloads
About
Search Substances
SAMALIZUMAB
64EUX713G6
Investigational
General
Names
7
Classification
1
Identifiers
9
Subunits
4
Related Substances
1
SAMALIZUMAB
64EUX713G6
Investigational
General
Approval Year
Unknown
149,124
Names
7
Show
5
20
100
All
entries
Name
Type
Language
Name
Type
Language
samalizumab [INN]
Preferred Name
English
SAMALIZUMAB
Official Name
English
ALXN-6000
Code
English
Samalizumab [WHO-DD]
Common Name
English
IMMUNOGLOBULIN, ANTI-(CD200 (ANTIGEN)) (HUMAN-MOUSE MONOCLONAL ALXN6000 HEAVY CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL ALXN6000 .KAPPA.-CHAIN, DIMER
Common Name
English
Showing 1 to 5 of 7 entries
Previous
1
2
Next
Classification
1
Show
5
20
100
All
entries
Classification Tree
Code System
Code
Classification Tree
Code System
Code
Biological Agent
Pharmacologic Substance
[C1909]
Biological Agent
[C307]
Monoclonal Antibody
NCI_THESAURUS
C20401
Showing 1 to 1 of 1 entries
Previous
1
Next
Identifiers
9
Show
5
20
100
All
entries
Code System
Code
Type
Description
Code System
Code
Type
Description
INN
9307
PRIMARY
CAS
1073059-33-2
PRIMARY
WIKIPEDIA
Samalizumab
PRIMARY
SMS_ID
300000021899
PRIMARY
DRUG BANK
DB12636
PRIMARY
Showing 1 to 5 of 9 entries
Previous
1
2
Next
Subunits
4
Subunit 0
>SUBUNIT_0
Subunit 1
>SUBUNIT_1
Subunit 2
>SUBUNIT_2
Subunit 3
>SUBUNIT_3
Related Substances
1
ACTIVE MOIETY
64EUX713G6
SAMALIZUMAB